Clinical Efficacy of Gemcitabine Plus Cisplatinum in Comparison with Gemcitabine Alone in the Elderly Patients with Advanced Non-small Cell Lung Cancer
BACKGROUND: Most elderly patients with non-small cell lung cancer (NSCLC) were in advanced stage, and could not undergo operation.This study aimed to analyze the efficacy and toxicity of gemcitabine plus cisplatinum in comparison with gemcitabine alone in patients aged 70 years or over with advanced NSCLC.
L.M.Sun Z.Y.Feng Y.Zhang Q.He L.L.Liu F.G.Chen Z.X.Dai
Department of Medical Oncology,the Second Hospital of Dalian Medical University, Dalian 116031, China
国内会议
苏州
英文
10-10
2015-09-11(万方平台首次上网日期,不代表论文的发表时间)